• Publications
  • Influence
Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
Programmed death 1 (PD-1) is a lymphoid receptor that negatively regulates immune responses. PD-1 expression was recently reported in some T-cell non-Hodgkin lymphoma (NHL) subtypes, but theExpand
  • 153
  • 13
A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients
Objective:The impact of a contributive result of open-lung biopsy on the outcome of patients with acute respiratory distress syndrome (ARDS) has not been extensively investigated. The aim of thisExpand
  • 174
  • 9
  • PDF
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.
The outcome of classical Hodgkin lymphoma (cHL) patients may be related to the tumor microenvironment, which in turn may be influenced by Epstein-Barr virus (EBV) infection. To characterize the cHLExpand
  • 196
  • 8
PD-1 is a novel regulator of human B-cell activation.
The outcome of the adaptive immune response is determined by the integration of both positive and negative signals, respectively, induced upon the triggering of co-signaling receptors. One of them,Expand
  • 164
  • 8
  • PDF
LAT regulates gammadelta T cell homeostasis and differentiation.
LAT (linker for activation of T cells) is essential for T cell receptor signaling. Mice homozygous for a mutation of the three C-terminal LAT tyrosine residues showed a block in alphabeta T cellExpand
  • 57
  • 6
Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?
OBJECTIVE To assess the therapeutic effect of the extent of lymph node dissection performed in patients with a stage pI non-small-cell lung cancer (NSCLC). METHODS We analysed data on 465 patientsExpand
  • 128
  • 4
Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behavior.
Neural cell adhesion molecule (NCAM), a member of the immunoglobulin superfamily, is expressed by a subgroup of renal cell carcinomas (RCCs) and by a limited number of adult organs, including theExpand
  • 40
  • 4
Primary Intrathoracic Synovial Sarcoma: A Clinicopathologic Study of 40 t(X;18)-Positive Cases From the French Sarcoma Group and the Mesopath Group
Synovial sarcoma (SS), an aggressive neoplasm accounting for up to 14% of soft tissue sarcomas, was recently recognized as a primary tumor in the lung and pleura. SS is characterized by theExpand
  • 127
  • 4
Completion pneumonectomy in cancer patients: experience with 55 cases.
OBJECTIVE Analysis of a single institution experience with completion pneumonectomy. METHODS From 1989 to 2002, 55 consecutive cancer patients received completion pneumonectomy (mean age 62 years;Expand
  • 48
  • 4
Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery.
BACKGROUND Assessment of clinical and pathologic features of large cell neuroendocrine carcinoma to confirm its specificity in the setting of high grade neuroendocrine pulmonary tumors. METHODSExpand
  • 50
  • 4